SEC Tracker
Get the app

Pyxis Oncology PYXS

Pyxis Oncology to hold virtual meeting on Nov 13

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Special meeting on Nov 13, 2026 at 10:00 a.m. EST
  2. Approval of charter amendment to increase common stock shares to 380M
  3. Stockholders of record on Oct 8, 2026 eligible to vote

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Pyxis Oncology files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Veru VERU public float $64M, Mar 31, 2025, over 18 months old
  2. Whitehawk Therapeutics WHWK public float $65M, Jun 30, 2025
  3. Lifevantage LFVN public float $64M, Dec 31, 2025
  4. Medicinova MNOV public float $62M, Jun 30, 2025
  5. Corbus Pharmaceuticals Holdings CRBP public float $68M, Jun 30, 2025